Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice.
- Published In:
- International journal of nanomedicine, 19, 35-51 (2024)
- Authors:
- Hu, Weinan, Cai, Wenting, Wu, Yan(4), Ren, Chengda, Yu, Donghui, Li, Tingting, Shen, Tianyi, Xu, Ding, Yu, Jing
- Database ID:
- RPEP-08404
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08404APA
Hu, Weinan; Cai, Wenting; Wu, Yan; Ren, Chengda; Yu, Donghui; Li, Tingting; Shen, Tianyi; Xu, Ding; Yu, Jing. (2024). Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice.. International journal of nanomedicine, 19, 35-51. https://doi.org/10.2147/IJN.S428684
MLA
Hu, Weinan, et al. "Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice.." International journal of nanomedicine, 2024. https://doi.org/10.2147/IJN.S428684
RethinkPeptides
RethinkPeptides Research Database. "Topical Application of Cell-Penetrating Peptide Modified Ant..." RPEP-08404. Retrieved from https://rethinkpeptides.com/research/hu-2024-topical-application-of-cellpenetrating
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.